XFLH Capital signs LOI for business combination with Renogen Biolab

Bitget2026/09/22 12:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

XFLH Capital signed a non-binding letter of intent for a business combination with Renogen Biolab, a Canadian health services provider.
Renogen provides molecular capabilities including DNA services, vector engineering, and protein expression.
Parties plan to negotiate definitive agreements as soon as practicable.
Mutual due diligence will begin, with each side granting access to information to support the review.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XFLH Capital Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-004190), on September 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

XFLH Capital signs LOI for business combination with Renogen Biolab

You may also like

Crypto prices